Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Other Accumulated Expenses (2016)

STRATA Skin Sciences' Other Accumulated Expenses history spans 6 years, with the latest figure at $1000.0 for Q2 2016.

  • On a quarterly basis, Other Accumulated Expenses changed N/A to $1000.0 in Q2 2016 year-over-year; TTM through Jun 2016 was $1000.0, a N/A change, with the full-year FY2015 number at $43000.0, down 81.62% from a year prior.
  • Other Accumulated Expenses hit $1000.0 in Q2 2016 for STRATA Skin Sciences, down from $13000.0 in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for SSKN hit a ceiling of $778000.0 in Q3 2015 and a floor of $1000.0 in Q2 2016.
  • Historically, Other Accumulated Expenses has averaged $113718.6 across 5 years, with a median of $59212.0 in 2013.
  • The widest YoY moves for Other Accumulated Expenses: up 480.29% in 2015, down 81.62% in 2015.
  • Tracing SSKN's Other Accumulated Expenses over 5 years: stood at $41000.0 in 2012, then surged by 65.85% to $68000.0 in 2013, then surged by 244.12% to $234000.0 in 2014, then crashed by 81.62% to $43000.0 in 2015, then plummeted by 97.67% to $1000.0 in 2016.
  • Business Quant data shows Other Accumulated Expenses for SSKN at $1000.0 in Q2 2016, $13000.0 in Q1 2016, and $43000.0 in Q4 2015.